❌

Normal view

There are new articles available, click to refresh the page.
Before yesterdayMain stream

CXMT Debuts With $8.6 Billion IPO As Its DRAM Surge Chips Away At Samsung’s Market Dominance By 2028

17 July 2026 at 10:35

A large, modern building with reflective glass and the 'GSMT' logo on the upper left corner.

CXMT is all set to tackle the "Big Three" in a significant way in the DRAM segment as it accelerates its memory product roadmap. DRAM Demand Turns CXMT Into A Major Memory Player, Gunning The Big Three With An Accelerated Roadmap Yesterday, CXMT made its stock market debut on the Shanghai STAR Board with an $8.6 billion IPO. While the company is valued at around $80-$85 billion, which puts it far below the $1.0 trillion that its competitors are valued at, the company is all set to tackle the "Big Three" big time with a roadmap that includes various products […]

Read full article at https://wccftech.com/cxmt-debuts-8-6-billion-ipo-as-dram-surge-chips-away-at-samsungs-dominance-by-2028/

Uber’s product chief on hotels, robotaxis, and why the company doesn’t want to be β€œeverything for everyone”

14 July 2026 at 00:45
Uber Chief Product Officer Sachin Kansal walks TechCrunch through the company's financial-services ambitions, its increasingly complicated relationship with Waymo, its new AV Labs data operation, and how AI is starting to show up in ways riders and drivers will actually notice.

Reed Jobs would rather talk about curing cancer than his last name

12 July 2026 at 00:16
When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs' words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.
❌
❌